Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognosis-modifying therapy in multiple sclerosis.

G Comi1, B Colombo, V Martinelli

  • 1University of Milan, Department of Neuroscience, Scientific Institute H. San Raffaele, Italy.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crossing the border between epileptic and vascular pathology: a report of CACNA1A-related treatment-resistant hemiplegic migraine.

Journal of neurology·2023
Same author

OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study.

Journal of neurology·2022
Same author

Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report.

Journal of neurology·2022
Same author

Assessing validity and reliability of a new tool: the ECSQ (Endoscopy Customer Satisfaction Question-naire) in Italian for customer satisfaction in digestive endoscopy.

Annali di igiene : medicina preventiva e di comunita·2022
Same author

Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family.

Multiple sclerosis and related disorders·2018
Same author

Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report.

Multiple sclerosis and related disorders·2018
Same journal

Hypogonadotrophic hypogonadism in GBA2 associated spastic paraplegia type 46 (SPG46): a phenotypic expansion.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Vibrotactile stimulation induces changes in basal ganglia output, cervical muscle activity, and head posture in a patient with cervical dystonia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Evaluating LLM diagnostic reasoning: a new frontier for clinical AI assessment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Asymmetrical muscular disorder with normal creatine kinase (CK) and electromyography (EMG): the challenging diagnosis of muscular polyarteritis nodosa (MPAN), case report and literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Neuropsychological assessment in adult epilepsy: rationale, test selection, and clinical integration across non-surgical care in Italian patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Early implementation of transradial mechanical thrombectomy in a primary stroke center: a sequential cohort propensity score-matched study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
See all related articles

Early treatment of relapsing-remitting multiple sclerosis (RRMS) with immunomodulatory drugs like interferon beta and COP-1 offers optimism. Starting therapy early can reduce relapse rates and pathological lesions, improving patient prognosis.

Area of Science:

  • Neurology
  • Immunology
  • Pathogenesis of Multiple Sclerosis

Background:

  • Neurological treatment perspectives for multiple sclerosis (MS) have shifted from pessimism to optimism.
  • Advances in understanding MS pathogenesis and development of MS-specific therapies (interferon beta, COP-1) have driven this change.

Purpose of the Study:

  • To evaluate the advantages of early immunomodulatory treatment in relapsing-remitting MS (RRMS) patients.
  • To support early intervention strategies for reducing disease activity and preventing irreversible pathological changes.

Main Methods:

  • Analysis of available immunological, clinical, and pathological data.
  • Review of therapeutic strategies for early-stage RRMS.

Main Results:

Related Experiment Videos

  • Early treatment of RRMS patients with immunomodulatory drugs appears more advantageous than delayed treatment.
  • Early intervention can reduce relapse rates and the extent of pathological lesions.

Conclusions:

  • Early treatment of RRMS is strategically beneficial, particularly in the initial disease phases.
  • Early therapy offers a rationale for preventing irreversible pathological changes and reducing clinical/MRI activity.
  • Interferon beta and COP-1 are currently the most suitable pharmacological agents for early MS treatment.